https://k858inhibitor.com/repo....rt-on-the-latest-adv
The independent predictors of PR to IC included classification as stage N3 disease, baseline carcinoembryonic antigen (CEA) levels 10 ng/ml, and cytokeratin fragment 19 (CYFRA21-1) levels 6 ng/ml. With every additional separate predictor, the likelihood of having have PR to IC increased. Conclusions Radiotherapy with induction and concurrent PP/DP chemotherapy is feasible for patients with unresectable Stage III NSCLC. IC may enhance the survival of IC responders, as predicted by